E-cadherin endocytosis promotes non-canonical EGFR:STAT signalling to induce cell death and inhibit heterochromatinisation
E-cadherin endocytosis promotes non-canonical EGFR:STAT signalling to induce cell death and inhibit heterochromatinisation
Signalling molecules often contribute to several downstream pathways that produce distinct transcriptional outputs and cellular phenotypes. One of the major unanswered questions in cell biology is how multiple activities of signalling molecules are coordinated in space and time in vivo. Here, we focus on the Signal Transducer and Activator of Transcription (STAT) protein as a paradigm of signalling molecules involved in several independent signalling pathways. Using Drosophila wing discs as an in vivo model, we demonstrate an interplay of at least three STAT activities in this tissue. In addition to the 'canonical' pathways, in which STAT is phosphorylated and activated by Janus Kinases, STAT is involved in two 'non-canonical' pathways. In one pathway, STAT is activated by the Epidermal Growth Factor Receptor (EGFR), promoting apoptosis. In the other, it binds the Heterochromatin Protein 1 (HP1) to enhance heterochromatin formation. We provide evidence that while the 'canonical' STAT signalling is dominant over 'non-canonical' pathways, EGFR:STAT and HP1:STAT pathways compete for the availability of unphosphorylated STAT. We also describe a central role for the cell-cell adhesion protein E-cadherin, with both EGFR and STAT colocalising with E-cadherin at cell-cell junctions and on intracellular vesicles. We show that elevated intracellular E-cadherin promotes EGFR:STAT pathway leading to apoptosis, which is prevented by inhibiting E-cad endocytosis. Taken together, we conclude that E-cadherin controls the balance between two non-canonical STAT activities. We hypothesise that this balance represents a tumour-suppressive mechanism, in which junctional disassembly in dysregulated epithelial-to-mesenchymal transitions would shift this balance towards the EGFR:STAT signalling to promote apoptosis.
Moreno, Miguel Ramirez
22b64166-df15-46e0-b5a5-2e99ea81d0da
Quinton, Amy
51bb5541-66f3-4250-986a-bf592fbfb748
Jacobsen, Eleanor
df3b8f02-74f2-4446-8636-61a277a97184
Stempor, Przemyslaw A.
87cb2817-4994-4547-a3db-a6603582cfb9
Zeidler, Martin P.
86b4240e-5278-4f9a-84d7-15f49d8e1f2f
Bulgakova, Natalia A.
f01bab85-42b3-403b-926c-3b56b17de5dd
Wappner, Pablo
89e595f9-0cb8-42b5-968f-d06cadf575d6
21 July 2025
Moreno, Miguel Ramirez
22b64166-df15-46e0-b5a5-2e99ea81d0da
Quinton, Amy
51bb5541-66f3-4250-986a-bf592fbfb748
Jacobsen, Eleanor
df3b8f02-74f2-4446-8636-61a277a97184
Wappner, Pablo
89e595f9-0cb8-42b5-968f-d06cadf575d6
Stempor, Przemyslaw A.
87cb2817-4994-4547-a3db-a6603582cfb9
Zeidler, Martin P.
86b4240e-5278-4f9a-84d7-15f49d8e1f2f
Bulgakova, Natalia A.
f01bab85-42b3-403b-926c-3b56b17de5dd
Moreno, Miguel Ramirez, Quinton, Amy, Jacobsen, Eleanor, Stempor, Przemyslaw A., Zeidler, Martin P. and Bulgakova, Natalia A.
,
Wappner, Pablo
(ed.)
(2025)
E-cadherin endocytosis promotes non-canonical EGFR:STAT signalling to induce cell death and inhibit heterochromatinisation.
PLoS Genetics, 21 (7 JULY), [e1011781].
(doi:10.1371/journal.pgen.1011781).
Abstract
Signalling molecules often contribute to several downstream pathways that produce distinct transcriptional outputs and cellular phenotypes. One of the major unanswered questions in cell biology is how multiple activities of signalling molecules are coordinated in space and time in vivo. Here, we focus on the Signal Transducer and Activator of Transcription (STAT) protein as a paradigm of signalling molecules involved in several independent signalling pathways. Using Drosophila wing discs as an in vivo model, we demonstrate an interplay of at least three STAT activities in this tissue. In addition to the 'canonical' pathways, in which STAT is phosphorylated and activated by Janus Kinases, STAT is involved in two 'non-canonical' pathways. In one pathway, STAT is activated by the Epidermal Growth Factor Receptor (EGFR), promoting apoptosis. In the other, it binds the Heterochromatin Protein 1 (HP1) to enhance heterochromatin formation. We provide evidence that while the 'canonical' STAT signalling is dominant over 'non-canonical' pathways, EGFR:STAT and HP1:STAT pathways compete for the availability of unphosphorylated STAT. We also describe a central role for the cell-cell adhesion protein E-cadherin, with both EGFR and STAT colocalising with E-cadherin at cell-cell junctions and on intracellular vesicles. We show that elevated intracellular E-cadherin promotes EGFR:STAT pathway leading to apoptosis, which is prevented by inhibiting E-cad endocytosis. Taken together, we conclude that E-cadherin controls the balance between two non-canonical STAT activities. We hypothesise that this balance represents a tumour-suppressive mechanism, in which junctional disassembly in dysregulated epithelial-to-mesenchymal transitions would shift this balance towards the EGFR:STAT signalling to promote apoptosis.
Text
journal.pgen.1011781
- Version of Record
More information
Accepted/In Press date: 23 June 2025
Published date: 21 July 2025
Identifiers
Local EPrints ID: 503661
URI: http://eprints.soton.ac.uk/id/eprint/503661
ISSN: 1553-7390
PURE UUID: 1c584cda-9f18-4101-ae90-a8c9c6259962
Catalogue record
Date deposited: 08 Aug 2025 16:34
Last modified: 22 Aug 2025 02:37
Export record
Altmetrics
Contributors
Author:
Miguel Ramirez Moreno
Author:
Amy Quinton
Author:
Eleanor Jacobsen
Editor:
Pablo Wappner
Author:
Przemyslaw A. Stempor
Author:
Martin P. Zeidler
Author:
Natalia A. Bulgakova
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics